Advanced search
Publication Cover
Climacteric Volume 20, 2017 - Issue 2
Submit an article Journal homepage
1,674
Views
96
CrossRef citations to date
0
Altmetric
Review

A Precision Medicine Initiative for Alzheimer’s disease: the road ahead to biomarker-guided integrative disease modeling

H. HampelAXA Research Fund & UPMC Chair, Paris, France; ;Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; Correspondence[email protected] [email protected]
,
S. E. O’BryantInstitute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX, USA;
,
S. DurrlemanARAMIS Lab, Inria Paris, Paris, France; ;Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du cerveau et la moelle (ICM), Hôpital Pitié-Salpêtrière, Boulevard de l’hôpital, Paris, France;
,
E. YounesiEuropean Society for Translational Medicine, Vienna, Austria;
,
K. RojkovaAXA Research Fund & UPMC Chair, Paris, France; ;Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France;
,
V. Escott-PriceMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK;
,
J-C. CorvolDépartement de Neurologie, Sorbonne Université, Université Pierre et Marie Curie, Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale (INSERM) U 1127 and CIC-1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France;
,
K. BroichPresident, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany
,
B. DuboisDépartement de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France;
,
S. ListaAXA Research Fund & UPMC Chair, Paris, France; ;Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Paris 06, Inserm, CNRS, Institut du cerveau et de la moelle (ICM), Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Paris, France; Correspondence[email protected] [email protected]
& for the Alzheimer Precision Medicine Initiative show all
Pages 107-118 | Received 22 Nov 2016, Accepted 08 Dec 2016, Published online: 09 Feb 2017

Citations (96)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Dubravka Svob Strac, Marcela Konjevod, Marina Sagud, Matea Nikolac Perkovic, Gordana Nedic Erjavec, Barbara Vuic, Goran Simic, Vana Vukic, Ninoslav Mimica & Nela Pivac. (2021) Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview. Pharmacogenomics and Personalized Medicine 14, pages 631-653.
Read now
Marina Sagud, Lucija Tudor & Nela Pivac. (2021) Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease. Expert Review of Neurotherapeutics 21:5, pages 571-589.
Read now
Filippo Baldacci, Sonia Mazzucchi, Alessandra Della Vecchia, Linda Giampietri, Nicola Giannini, Maya Koronyo-Hamaoui, Roberto Ceravolo, Gabriele Siciliano, Ubaldo Bonuccelli, Fanny M. Elahi, Andrea Vergallo, Simone Lista, Filippo Sean Giorgi & Harald Hampel. (2020) The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Review of Molecular Diagnostics 20:4, pages 421-441.
Read now
Filippo Baldacci, Simone Lista, Giovanni Palermo, Filippo Sean Giorgi, Andrea Vergallo & Harald Hampel. (2019) The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development. Expert Review of Proteomics 16:7, pages 593-600.
Read now
Harald Hampel, Andrea Vergallo, Mohammad Afshar, Leyla Akman-Anderson, Joaquín Arenas, Norbert Benda, Richard Batrla, Karl Broich, Filippo Caraci, A. Claudio Cuello, Enzo Emanuele, Marion Haberkamp, Steven J. Kiddle, Alejandro Lucía, Mark Mapstone, Steven R. Verdooner, Janet Woodcock & Simone Lista. (2019) Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
. Dialogues in Clinical Neuroscience 21:2, pages 177-191.
Read now
Ramón Cacabelos. (2018) Population-level pharmacogenomics for precision drug development in dementia. Expert Review of Precision Medicine and Drug Development 3:3, pages 163-188.
Read now
Filippo Baldacci, Simone Lista, Enrica Cavedo, Ubaldo Bonuccelli & Harald Hampel. (2017) Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases. Expert Review of Proteomics 14:4, pages 285-299.
Read now

Articles from other publishers (89)

Julien Delrieu, Bruno Vellas, Sophie Guyonnet, Christelle Cantet, Vitaliy Ovod, Yan Li, James Bollinger, Randall Bateman, Sandrine Andrieu, Isabelle Carrié, Lauréane Brigitte, Catherine Faisant, Françoise Lala, Hélène Villars, Emeline Combrouze, Carole Badufle, Audrey Zueras, Christophe Morin, Gabor Abellan Van Kan, Charlotte Dupuy, Yves Rolland, Céline Caillaud, Pierre-Jean Ousset, Sherry Willis, Sylvie Belleville, Brigitte Gilbert, Francine Fontaine, Jean-François Dartigues, Isabelle Marcet, Fleur Delva, Alexandra Foubert, Sandrine Cerda, Marie-Noëlle-Cuffi, Corinne Costes, Olivier Rouaud, Patrick Manckoundia, Valérie Quipourt, Sophie Marilier, Evelyne Franon, Lawrence Bories, Marie-Laure Pader, Marie-France Basset, Bruno Lapoujade, Valérie Faure, Michael Li Yung Tong, Christine Malick-Loiseau, Evelyne Cazaban-Campistron, Françoise Desclaux, Colette Blatge, Thierry Dantoine, Cécile Laubarie-Mouret, Isabelle Saulnier, Jean-Pierre Clément, Marie-Agnès Picat, Laurence Bernard-Bourzeix, Stéphanie Willebois, Iléana Désormais, Noëlle Cardinaud, Marc Bonnefoy, Pierre Livet, Pascale Rebaudet, Claire Gédéon, Catherine Burdet, Flavien Terracol, Alain Pesce, Stéphanie Roth, Sylvie Chaillou, Sandrine Louchart, Kristel Sudres, Nicolas Lebrun, Nadège Barro-Belaygues, Jacques Touchon, Karim Bennys, Audrey Gabelle, Aurélia Romano, Lynda Touati, Cécilia Marelli, Cécile Pays, Philippe Robert, Franck Le Duff, Claire Gervais, Sébastien Gonfrier, Yannick Gasnier, Serge Bordes, Danièle Begorre, Christian Carpuat, Khaled Khales, Jean-François Lefebvre, Samira Misbah El Idrissi, Pierre Skolil, Jean-Pierre Salles & Nicola Coley. (2023) Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial. Alzheimer's Research & Therapy 15:1.
Crossref
Sid E. O’Bryant, Fan Zhang, Leigh A. Johnson, James Hall, Melissa Petersen, Esther S. Oh, Constantine G. Lyketsos & Robert A. Rissman. (2023) Precision Medicine for Preventing Alzheimer’s Disease: Analysis of the ADAPT Study. Journal of Alzheimer's Disease, pages 1-14.
Crossref
Li Yang, Qilong Tan, Wenjing Wan, Zhibin Bu, Cheng Xuan, Caiyan Yu, Jiong Wu & Jing Yan. (2023) A blood-based, metabolite and demographic characteristic markers panel for the diagnosis of Alzheimer's disease. Bioanalysis.
Crossref
T.C Venkateswarulu, Vajiha, S. Krupanidhi, Indira Mikkili, Jacinth Angelina, D. John Babu & K. Abraham Peele. (2022) In silico study on evaluation of corosolic acid of Lagerstroemia speciosa against Alzheimer’s disease . Arab Gulf Journal of Scientific Research 41:2, pages 175-182.
Crossref
Laura Pérez-Cano, Sara Azidane Chenlo, Rubén Sabido-Vera, Francesco Sirci, Lynn Durham & Emre Guney. (2023) Translating precision medicine for autism spectrum disorder: A pressing need. Drug Discovery Today 28:3, pages 103486.
Crossref
Azher Arafah, Saima Khatoon, Iyman Rasool, Andleeb Khan, Mashoque Ahmad Rather, Khaled Abdullah Abujabal, Yazid Abdullilah Hassan Faqih, Hina Rashid, Shahzada Mudasir Rashid, Sheikh Bilal Ahmad, Athanasios Alexiou & Muneeb U. Rehman. (2023) The Future of Precision Medicine in the Cure of Alzheimer’s Disease. Biomedicines 11:2, pages 335.
Crossref
Najwa-Joelle Metri, Ali S Butt, Ava Murali, Genevieve Z Steiner-Lim & Chai K Lim. (2023) Normative Data on Serum and Plasma Tryptophan and Kynurenine Concentrations from 8089 Individuals Across 120 Studies: A Systematic Review and Meta-Analysis. International Journal of Tryptophan Research 16.
Crossref
Ebru Emekli-Alturfan & A. Ata Alturfan. (2022) The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence. Molecular Biology Reports 50:1, pages 815-828.
Crossref
Chidinma Promise Anyachor, Donatus Baridoo Dooka, Chinna Nneka Orish, Cecilia Nwadiuto Amadi, Beatrice Bocca, Flavia Ruggieri, Marta Senofonte, Chiara Frazzoli & Orish E. Orisakwe. (2022) Mechanistic considerations and biomarkers level in nickel-induced neurodegenerative diseases: An updated systematic review. IBRO Neuroscience Reports 13, pages 136-146.
Crossref
Arianna Menardi, Lisa Dotti, Ettore Ambrosini & Antonino Vallesi. (2022) Transcranial magnetic stimulation treatment in Alzheimer’s disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization. Journal of Neurology 269:10, pages 5283-5301.
Crossref
Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo O. Fapohunda, Peng Lü, Kun Wang & Min Tang. (2022) Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?. Frontiers in Aging Neuroscience 14.
Crossref
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, Valentina Floris, Elisa Pierella, Gabriele Savioli, Sakshi Prasad, Ciro Esposito, Giovanni Ricevuti, Salvatore Chirumbolo & Alessia Pascale. (2022) Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview. Cells 11:8, pages 1367.
Crossref
Mohammad Nami, Robert Thatcher, Nasser Kashou, Dahabada Lopes, Maria Lobo, Joe F. Bolanos, Kevin Morris, Melody Sadri, Teshia Bustos, Gilberto E. Sanchez, Alena Mohd-Yusof, John Fiallos, Justin Dye, Xiaofan Guo, Nicholas Peatfield, Milena Asiryan, Alero Mayuku-Dore, Solventa Krakauskaite, Ernesto Palmero Soler, Steven C. Cramer, Walter G. Besio, Antal Berenyi, Manjari Tripathi, David Hagedorn, Morgan Ingemanson, Marinela Gombosev, Mark Liker, Yousef Salimpour, Martin Mortazavi, Eric Braverman, Leslie S. Prichep, Deepak Chopra, Dawn S. Eliashiv, Robert Hariri, Ambooj Tiwari, Ken Green, Jason Cormier, Namath Hussain, Nevzat Tarhan, Daniel Sipple, Michael Roy, John S. Yu, Aaron Filler, Mike Chen, Chris Wheeler, J. Wesson Ashford, Kenneth Blum, Deborah Zelinsky, Vicky Yamamoto & Babak Kateb. (2022) A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics. Journal of Alzheimer's Disease 86:1, pages 21-42.
Crossref
Karl Herholz. (2022) Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer’s Disease. Brain Sciences 12:2, pages 146.
Crossref
Forough Taheri, Monika Frenzel, Pirooz Ebrahimi, Negar Sarhangi, Mandana Hasanzad & Mahsa M. Amoli. 2022. Precision Medicine in Clinical Practice. Precision Medicine in Clinical Practice 151 170 .
Jelena Bezold, Sandra Trautwein, Bettina Barisch-Fritz, Andrea Scharpf, Janina Krell-Roesch, Claudio R. Nigg & Alexander Woll. (2021) Effects of a 16-week multimodal exercise program on activities of daily living in institutionalized individuals with dementiaAuswirkungen eines 16-wöchigen multimodalen Trainingsprogramms auf die Aktivitäten des täglichen Lebens bei Heimbewohnern mit Demenz. German Journal of Exercise and Sport Research 51:4, pages 506-517.
Crossref
Gayatri Gawade, Sameer A Chaudhary, Sapana Chaudhary, Sakshi Rawat, Anwar L Bilgrami & Meghana Padwal. (2021) Next generation sequencing: A promising tool to explore the personalized medicine in understanding the neurodegenerative diseases. International Journal of Clinical Biochemistry and Research 8:3, pages 153-162.
Crossref
Andrea Zangrossi, Sonia Montemurro, Gianmarco Altoè & Sara Mondini. (2021) Heterogeneity and Factorial Structure in Alzheimer’s Disease: A Cognitive Perspective. Journal of Alzheimer's Disease 83:3, pages 1341-1351.
Crossref
Parminder S. Reel, Smarti Reel, Ewan Pearson, Emanuele Trucco & Emily Jefferson. (2021) Using machine learning approaches for multi-omics data analysis: A review. Biotechnology Advances 49, pages 107739.
Crossref
Pia Rivetti di Val Cervo, Dario Besusso, Paola Conforti & Elena Cattaneo. (2021) hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nature Reviews Neurology 17:6, pages 381-392.
Crossref
Joseph M. Schulz. (2021) The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease. Stem Cells International 2021, pages 1-16.
Crossref
Sid E. O’Bryant, Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall & Robert A. Rissman. (2021) A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials. Journal of Alzheimer's Disease 81:2, pages 557-568.
Crossref
Ray O. Bahado-Singh, Sangeetha Vishweswaraiah, Buket Aydas, Ali Yilmaz, Raghu P. Metpally, David J. Carey, Richard C. Crist, Wade H. Berrettini, George D. Wilson, Khalid Imam, Michael Maddens, Halil Bisgin, Stewart F. Graham & Uppala Radhakrishna. (2021) Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer’s disease. PLOS ONE 16:3, pages e0248375.
Crossref
Matea Nikolac Perkovic, Alja Videtic Paska, Marcela Konjevod, Katarina Kouter, Dubravka Svob Strac, Gordana Nedic Erjavec & Nela Pivac. (2021) Epigenetics of Alzheimer’s Disease. Biomolecules 11:2, pages 195.
Crossref
Gregory Penner, Soizic Lecocq, Anaëlle Chopin, Ximena Vedoya, Simone Lista, Andrea Vergallo, Enrica Cavedo, Francois-Xavier Lejeune, Bruno Dubois & Harald Hampel. (2021) Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease. PLOS ONE 16:1, pages e0243902.
Crossref
Michelle R. Campbell, Susan Ashrafzadeh‐Kian, Ronald C. Petersen, Michelle M. Mielke, Jeremy A. Syrjanen, Argonde C. van Harten, Val J. Lowe, Clifford R. JackJrJr, Joshua A. Bornhorst & Alicia Algeciras‐Schimnich. (2021) P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13:1.
Crossref
Filippo Baldacci, Simone Lista, Maria Laura Manca, Patrizia A. Chiesa, Enrica Cavedo, Pablo Lemercier, Henrik Zetterberg, Kaj Blennow, Marie-Odile Habert, Marie Claude Potier, Bruno Dubois, Andrea Vergallo & Harald Hampel. (2020) Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study. Alzheimer's Research & Therapy 12:1.
Crossref
Gianluigi Forloni. (2020) Alzheimer’s disease: from basic science to precision medicine approach. BMJ Neurology Open 2:2, pages e000079.
Crossref
Giovanni Palermo, Sonia Mazzucchi, Alessandra Della Vecchia, Gabriele Siciliano, Ubaldo Bonuccelli, Carole Azuar, Roberto Ceravolo, Simone Lista, Harald Hampel & Filippo Baldacci. (2020) Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases. Molecular Neurobiology 57:11, pages 4667-4691.
Crossref
Yuhai Zhao, Vivian Jaber, Peter N. Alexandrov, Andrea Vergallo, Simone Lista, Harald Hampel & Walter J. Lukiw. (2020) microRNA-Based Biomarkers in Alzheimer’s Disease (AD). Frontiers in Neuroscience 14.
Crossref
Bing Li, Haijie Tan, David Jenkins, Vikram Srinivasa Raghavan, Bruno Gil Rosa, Firat Güder, Genhua Pan, Eric Yeatman & David J. Sharp. (2020) Clinical detection of neurodegenerative blood biomarkers using graphene immunosensor. Carbon 168, pages 144-162.
Crossref
Pedro L. Valenzuela, Adrián Castillo-García, Javier S. Morales, Pedro de la Villa, Harald Hampel, Enzo Emanuele, Simone Lista & Alejandro Lucia. (2020) Exercise benefits on Alzheimer’s disease: State-of-the-science. Ageing Research Reviews 62, pages 101108.
Crossref
Emily Baker & Valentina Escott-Price. (2020) Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions. Frontiers in Digital Health 2.
Crossref
Jaclyn Iannucci, William Renehan & Paula Grammas. (2020) Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer’s Disease. Frontiers in Neuroscience 14.
Crossref
Chiara Villa, Marialuisa Lavitrano, Elena Salvatore & Romina Combi. (2020) Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights. Journal of Personalized Medicine 10:3, pages 61.
Crossref
Kuo-Liang Chiang, Chin-Yin Huang, Liang-Po Hsieh & Kai-Ping Chang. (2020) A propositional AI system for supporting epilepsy diagnosis based on the 2017 epilepsy classification: Illustrated by Dravet syndrome. Epilepsy & Behavior 106, pages 107021.
Crossref
Stephan Heckers. 2020. Levels of Analysis in Psychopathology. Levels of Analysis in Psychopathology 450 456 .
Guive Sharifi, Amir Mohammad Pajavand, Saeedeh Nateghinia, Tohid Emami Meybodi & Hossein Hasooni. (2020) Glioma Migration Through the Corpus Callosum and the Brainstem Detected by Diffusion and Magnetic Resonance Imaging: Initial Findings. Frontiers in Human Neuroscience 13.
Crossref
Sepehr Golriz Khatami, Christine Robinson, Colin Birkenbihl, Daniel Domingo-Fernández, Charles Tapley Hoyt & Martin Hofmann-Apitius. (2020) Challenges of Integrative Disease Modeling in Alzheimer's Disease. Frontiers in Molecular Biosciences 6.
Crossref
Enrica CavedoSimone ListaMarion HouotAndrea VergalloMichel J. GrotheStefan TeipelHenrik ZetterbergKaj BlennowMarie-Odile HabertMarie C. PotierBruno DuboisHarald Hampel. (2020) Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Neurology 94:1.
Crossref
Iman M. Higazy. (2020) Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s. Saudi Pharmaceutical Journal 28:1, pages 33-57.
Crossref
Carole H. Sudre, M. Jorge Cardoso, Marc Modat & Sebastien Ourselin. 2020. Handbook of Medical Image Computing and Computer Assisted Intervention. Handbook of Medical Image Computing and Computer Assisted Intervention 343 378 .
Ravi Sharma, Charcy Zhang, Stephen C. Wingreen, Nir Kshetri & Arnob Zahid. (2019) Design of Blockchain-based Precision Health-Care Using Soft Systems Methodology. Industrial Management & Data Systems 120:3, pages 608-632.
Crossref
Jeffrey Cummings, Howard H. Feldman & Philip Scheltens. (2019) The “rights” of precision drug development for Alzheimer’s disease. Alzheimer's Research & Therapy 11:1.
Crossref
Richard S. Isaacson, Hollie Hristov, Nabeel Saif, Katherine Hackett, Suzanne Hendrix, Juan Melendez, Joseph Safdieh, Matthew Fink, Madhav Thambisetty, George Sadek, Sonia Bellara, Paige Lee, Cara Berkowitz, Aneela Rahman, Josefina Meléndez‐Cabrero, Emily Caesar, Randy Cohen, Pei‐lin Lu, Samuel P. Dickson, Mu Ji Hwang, Olivia Scheyer, Monica Mureb, Matthew W. Schelke, Kellyann Niotis, Christine E. Greer, Peter Attia, Lisa Mosconi & Robert Krikorian. (2019) Individualized clinical management of patients at risk for Alzheimer's dementia. Alzheimer's & Dementia 15:12, pages 1588-1602.
Crossref
S. Bulgakova, P. Romanchuk, N. Romanchuk, V. Pyatin, D. Romanov & A. Volobuev. (2019) Alzheimer’s Disease and Artificial Intelligence: Long-term Personalized Rehabilitation and Medical and Social Support. Bulletin of Science and Practice 5:11, pages 136-175.
Crossref
Nicola Toschi, Simone Lista, Filippo Baldacci, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Marie-Odile Habert, Bruno Dubois, Roberto Floris, Francesco Garaci, Andrea Vergallo, Harald Hampel, Hovagim Bakardjian, Habib Benali, Hugo Bertin, Joel Bonheur, Laurie Boukadida, Nadia Boukerrou, Enrica Cavedo, Patrizia Chiesa, Olivier Colliot, Bruno Dubois, Marion Dubois, Stéphane Epelbaum, Geoffroy Gagliardi, Remy Genthon, Marie-Odile Habert, Harald Hampel, Marion Houot, Aurélie Kas, Foudil Lamari, Marcel Levy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie-Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo & Nadjia Younsi. (2019) Biomarker-guided clustering of Alzheimer's disease clinical syndromes. Neurobiology of Aging 83, pages 42-53.
Crossref
Changtae Hahn & Chang Uk Lee. (2019) A Brief Review of Paradigm Shifts in Prevention of Alzheimer’s Disease: From Cognitive Reserve to Precision Medicine. Frontiers in Psychiatry 10.
Crossref
Harald Hampel, Simone Lista, Christian Neri & Andrea Vergallo. (2019) Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer’s disease. Progress in Neurobiology 181, pages 101662.
Crossref
Andrea Vergallo, Marion Houot, Enrica Cavedo, Pablo Lemercier, Eugeen Vanmechelen, Ann De Vos, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois, Simone Lista & Harald Hampel. (2019) Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD. Alzheimer's & Dementia 15:10, pages 1274-1285.
Crossref
Natalia Soldevila-Domenech, Anna Boronat, Klaus Langohr & Rafael de la Torre. (2019) N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function. Frontiers in Nutrition 6.
Crossref
Patrizia A. Chiesa, Enrica Cavedo, Andrea Vergallo, Simone Lista, Marie‐Claude Potier, Marie‐Odile Habert, Bruno Dubois, Michel Thiebaut de Schotten & Harald Hampel. (2019) Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease. Alzheimer's & Dementia 15:7, pages 940-950.
Crossref
Briseida E. Feliciano-Astacio, Katrina Celis, Jairo Ramos, Farid Rajabli, Larry Deon Adams, Alejandra Rodriguez, Vanessa Rodriguez, Parker L. Bussies, Carolina Sierra, Patricia Manrique, Pedro R. Mena, Antonella Grana, Michael Prough, Kara L. Hamilton-Nelson, Nereida Feliciano, Angel Chinea, Heriberto Acosta, Jacob L. McCauley, Jeffery M. Vance, Gary W. Beecham, Margaret A. Pericak-Vance & Michael L. Cuccaro. (2019) The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach. Frontiers in Genetics 10.
Crossref
Harald Hampel, Simone Lista, Dalila Mango, Robert Nisticò, George Perry, Jesus Avila, Felix Hernandez, Hugo Geerts & Andrea Vergallo. (2019) Lithium as a Treatment for Alzheimer’s Disease: The Systems Pharmacology Perspective. Journal of Alzheimer's Disease 69:3, pages 615-629.
Crossref
Andrea Vergallo, Lucile Mégret, Simone Lista, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Eugeen Vanmechelen, Ann De Vos, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois, Christian Neri & Harald Hampel. (2019) Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. Alzheimer's & Dementia 15:6, pages 764-775.
Crossref
Patrick Müllers, Marco Taubert & Notger G. Müller. (2019) Physical Exercise as Personalized Medicine for Dementia Prevention?. Frontiers in Physiology 10.
Crossref
Ruth Nussinov, Hyunbum Jang, Chung-Jung Tsai & Feixiong Cheng. (2019) Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. PLOS Computational Biology 15:3, pages e1006658.
Crossref
Harald Hampel, Andrea Vergallo, George Perry & Simone Lista. (2019) The Alzheimer Precision Medicine Initiative. Journal of Alzheimer's Disease 68:1, pages 1-24.
Crossref
Teresa Jenica Filshtein, Brittany N. Dugger, Lee-Way Jin, John M. Olichney, Sarah T. Farias, Luis Carvajal-Carmona, Paul Lott, Dan Mungas, Bruce Reed, Laurel A. Beckett & Charles DeCarli. (2019) Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer’s Disease Center. Journal of Alzheimer's Disease 68:1, pages 145-158.
Crossref
Ruth Nussinov, Hyunbum Jang, Chung-Jung Tsai & Feixiong Cheng. (2019) Precision medicine review: rare driver mutations and their biophysical classification. Biophysical Reviews 11:1, pages 5-19.
Crossref
Ying Yu, Yunjin Wang, Zhaojie Xia, Xiangyu Zhang, Kailiang Jin, Jingcheng Yang, Luyao Ren, Zheng Zhou, Dong Yu, Tao Qing, Chengdong Zhang, Li Jin, Yuanting Zheng, Li Guo & Leming Shi. (2019) PreMedKB: an integrated precision medicine knowledgebase for interpreting relationships between diseases, genes, variants and drugs. Nucleic Acids Research 47:D1, pages D1090-D1101.
Crossref
Zuo-Teng Wang, Chen-Chen Tan, Lan Tan & Jin-Tai Yu. (2019) Systems biology and gene networks in Alzheimer’s disease. Neuroscience & Biobehavioral Reviews 96, pages 31-44.
Crossref
Matea Nikolac Perkovic & Nela Pivac. 2019. Frontiers in Psychiatry. Frontiers in Psychiatry 27 52 .
Kuldeep Kumar, Matthew Toews, Laurent Chauvin, Olivier Colliot & Christian Desrosiers. (2018) Multi-modal brain fingerprinting: A manifold approximation based framework. NeuroImage 183, pages 212-226.
Crossref
Andrea Vergallo, René‐Sosata Bun, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Enrica Cavedo, Foudil Lamari, Marie‐Odile Habert, Bruno Dubois, Roberto Floris, Francesco Garaci, Simone Lista & Harald Hampel. (2018) Association of cerebrospinal fluid α‐synuclein with total and phospho‐tau 181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers . Alzheimer's & Dementia 14:12, pages 1623-1631.
Crossref
M. W. Vegter. (2018) Towards precision medicine; a new biomedical cosmology. Medicine, Health Care and Philosophy 21:4, pages 443-456.
Crossref
José Luis Molinuevo, Scott Ayton, Richard Batrla, Martin M. Bednar, Tobias Bittner, Jeffrey Cummings, Anne M. Fagan, Harald Hampel, Michelle M. Mielke, Alvydas Mikulskis, Sid O’Bryant, Philip Scheltens, Jeffrey Sevigny, Leslie M. Shaw, Holly D. Soares, Gary Tong, John Q. Trojanowski, Henrik Zetterberg & Kaj Blennow. (2018) Current state of Alzheimer’s fluid biomarkers. Acta Neuropathologica 136:6, pages 821-853.
Crossref
Harald Hampel, Sid E. O’Bryant, José L. Molinuevo, Henrik Zetterberg, Colin L. Masters, Simone Lista, Steven J. Kiddle, Richard Batrla & Kaj Blennow. (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology 14:11, pages 639-652.
Crossref
Sid E. O’Bryant, Fan Zhang, Leigh A. Johnson, James Hall, Melissa Edwards, Paula Grammas, Esther Oh, Constantine G. Lyketsos & Robert A. Rissman. (2018) A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease. Journal of Alzheimer's Disease 66:1, pages 97-104.
Crossref
Andrea R. Zammit, Charles B. Hall, Mindy J. Katz, Graciela Muniz-Terrera, Ali Ezzati, David A. Bennett & Richard B. Lipton. (2018) Class-Specific Incidence of All-Cause Dementia and Alzheimer’s Disease: A Latent Class Approach. Journal of Alzheimer's Disease 66:1, pages 347-357.
Crossref
Shinya Tasaki, Chris Gaiteri, Sara Mostafavi, Philip L. De Jager & David A. Bennett. (2018) The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia. Frontiers in Neuroscience 12.
Crossref
Shraddha Sapkota, Tao Huan, Tran Tran, Jiamin Zheng, Richard Camicioli, Liang Li & Roger A. Dixon. (2018) Alzheimer’s Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers. Frontiers in Aging Neuroscience 10.
Crossref
Enrica Cavedo, Patrizia A. Chiesa, Marion Houot, Maria Teresa Ferretti, Michel J. Grothe, Stefan J. Teipel, Simone Lista, Marie‐Odile Habert, Marie‐Claude Potier, Bruno Dubois & Harald Hampel. (2018) Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints. Alzheimer's & Dementia 14:9, pages 1204-1215.
Crossref
Stefan J. Teipel, Enrica Cavedo, Simone Lista, Marie‐Odile Habert, Marie‐Claude Potier, Michel J. Grothe, Stephane Epelbaum, Luisa Sambati, Geoffroy Gagliardi, Nicola Toschi, Michael D. Greicius, Bruno Dubois & Harald Hampel. (2018) Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT‐preAD study. Alzheimer's & Dementia 14:9, pages 1126-1136.
Crossref
Maria Teresa Ferretti, Maria Florencia Iulita, Enrica Cavedo, Patrizia Andrea Chiesa, Annemarie Schumacher Dimech, Antonella Santuccione Chadha, Francesca Baracchi, Hélène Girouard, Sabina Misoch, Ezio Giacobini, Herman Depypere & Harald Hampel. (2018) Sex differences in Alzheimer disease — the gateway to precision medicine. Nature Reviews Neurology 14:8, pages 457-469.
Crossref
Harald Hampel, Andrea Vergallo, Filippo Sean Giorgi, Seung Hyun Kim, Herman Depypere, Manuela Graziani, Amira Saidi, Robert Nisticò & Simone Lista. (2018) Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification. Frontiers in Neuroendocrinology 50, pages 31-51.
Crossref
Christine M. Dengler-Crish, Hope C. Ball, Li Lin, Kimberly M. Novak & Lisa Noelle Cooper. (2018) Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease. Neurobiology of Aging 67, pages 148-158.
Crossref
Harald Hampel, Nicola Toschi, Claudio Babiloni, Filippo Baldacci, Keith L. Black, Arun L.W. Bokde, René S. Bun, Francesco Cacciola, Enrica Cavedo, Patrizia A. Chiesa, Olivier Colliot, Cristina-Maria Coman, Bruno Dubois, Andrea Duggento, Stanley Durrleman, Maria-Teresa Ferretti, Nathalie George, Remy Genthon, Marie-Odile Habert, Karl Herholz, Yosef Koronyo, Maya Koronyo-Hamaoui, Foudil Lamari, Todd Langevin, Stéphane Lehéricy, Jean Lorenceau, Christian Neri, Robert Nisticò, Francis Nyasse-Messene, Craig Ritchie, Simone Rossi, Emiliano Santarnecchi, Olaf Sporns, Steven R. Verdooner, Andrea Vergallo, Nicolas Villain, Erfan Younesi, Francesco Garaci & Simone Lista. (2018) Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease 64:s1, pages S47-S105.
Crossref
Serge Gauthier, Kok Pin Ng, Tharick A. Pascoal, Hua Zhang & Pedro Rosa-Neto. (2018) Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment. Journal of Alzheimer's Disease 64:s1, pages S23-S31.
Crossref
Cheng-Xin Gong, Fei Liu & Khalid Iqbal. (2018) Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease. Journal of Alzheimer's Disease 64:s1, pages S107-S117.
Crossref
Harald Hampel, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Remy Genthon, Bruno Dubois, Roberto Floris, Francesco Garaci & Simone Lista. (2018) Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40 . Alzheimer's & Dementia 14:4, pages 492-501.
Crossref
David A. Hart. (2018) Would Adding Low Doses of Lithium Salts and/or Prebiotic Fibre Interventions to an Effective Exercise Protocol Further Enhance Retention of Cognitive Integrity? Potential for Preventing Loss of Cognition with Aging Using Combinations of Low Cost Regimens. Journal of Biomedical Science and Engineering 11:01, pages 1-9.
Crossref
Filippo Baldacci, Simone Lista, Sid E. O’Bryant, Roberto Ceravolo, Nicola Toschi & Harald Hampel. 2018. Biomarkers for Alzheimer’s Disease Drug Development. Biomarkers for Alzheimer’s Disease Drug Development 139 155 .
Juan I. Castrillo, Simone Lista, Harald Hampel & Craig W. Ritchie. 2018. Biomarkers for Alzheimer’s Disease Drug Development. Biomarkers for Alzheimer’s Disease Drug Development 31 66 .
Jeffrey Cummings. (2017) Disease modification and Neuroprotection in neurodegenerative disorders. Translational Neurodegeneration 6:1.
Crossref
Harald Hampel, Marsel M. Mesulam, A. Claudio Cuello, Ara S. Khachaturian, Martin R. Farlow, Peter J. Snyder, Ezio Giacobini & Zaven S. Khachaturian. (2017) WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. Alzheimer's & Dementia.
Crossref
Simone Lista, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan J. Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Bruno Dubois, Robert Nisticò, Roberto Floris, Francesco Garaci & Harald Hampel. (2017) Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study. Journal of Alzheimer's Disease 59:4, pages 1327-1334.
Crossref
Patrizia A. Chiesa, Enrica Cavedo, Simone Lista, Paul M. Thompson & Harald Hampel. (2017) Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer’s Disease. Trends in Neurosciences 40:8, pages 469-480.
Crossref
I. Koval, J.-B. Schiratti, A. Routier, M. Bacci, O. Colliot, S. Allassonnière & S. Durrleman. 2017. Medical Image Computing and Computer Assisted Intervention − MICCAI 2017. Medical Image Computing and Computer Assisted Intervention − MICCAI 2017 451 459 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.